20/20 BIOLABS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $4.1M
Liabilities Breakdown FY2025
Total Liabilities: $4.2M
Asset Breakdown
Total Assets: $4.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.0M | 24.8% |
| Accounts Receivable | $200.0K | 4.8% |
| Inventory | $116.2K | 2.8% |
| Property, Plant & Equipment | $56.7K | 1.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $202.3K | 4.9% |
| Other Assets | $2.5M | 61.3% |
Liabilities Breakdown
Total Liabilities: $4.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $868.5K | 20.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.3M | 79.1% |